[HTML][HTML] Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis

J Li, O Fadare, L Xiang, B Kong, W Zheng - Journal of hematology & …, 2012 - Springer
Recent morphologic and molecular genetic studies have led to a paradigm shift in our
conceptualization of the carcinogenesis and histogenesis of pelvic (non-uterine) serous …

[HTML][HTML] Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis

Q Zhang, W Li, MJ Kanis, G Qi, M Li, X Yang, B Kong - Oncotarget, 2017 - ncbi.nlm.nih.gov
OBJECTIVE The objectives of this study were to evaluate the rates of recurrence, survival
and pregnancy, and characterize pregnancy outcomes of early-stage cervical cancer (eCC) …

A proposed model for endometrial serous carcinogenesis

…, L Xiang, O Fadare, B Kong - The American journal of …, 2011 - journals.lww.com
Endometrial serous carcinomas constitute no more than 10% of endometrial adenocarcinomas,
but frequently present at an advanced stage and have a significantly worse prognosis …

High levels of Nrf2 determine chemoresistance in type II endometrial cancer

T Jiang, N Chen, F Zhao, XJ Wang, B Kong, W Zheng… - Cancer research, 2010 - AACR
Type II endometrial cancer, which mainly presents as serous and clear cell types, has
proved to be the most malignant and recurrent carcinoma among various female genital …

Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer

…, C Yuan, S Yan, Q Yang, J Chen, B Kong - …, 2011 - iopscience.iop.org
The treatment of ovarian cancer has traditionally been intractable, and required novel
approaches to improve therapeutic efficiency. This paper reports that thio-glucose bound gold …

[HTML][HTML] Tubal origin of 'ovarian'low-grade serous carcinoma

…, S Pang, L Xiang, SK Chambers, O Fadare, B Kong… - Modern Pathology, 2011 - Elsevier
Ovarian low-grade serous carcinomas are thought to evolve in a stepwise fashion from
ovarian epithelial inclusions, cystadenomas, and borderline tumors. The current study was …

Micro‐RNA‐21 regulates TGF‐β‐induced myofibroblast differentiation by targeting PDCD4 in tumor‐stroma interaction

…, S Cao, C Li, A Mengesha, B Kong… - International journal of …, 2011 - Wiley Online Library
Transforming growth factor‐β1 (TGF‐β1) induces stromal fibroblast‐to‐myofibroblast
transdifferentiation in the tumor‐stroma interactive microenvironment via modulation of multiple …

[HTML][HTML] Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study

…, R Chen, C Xu, R Yu, J Wang, S Xu, B Kong… - The Lancet Digital …, 2022 - thelancet.com
Background Ultrasound is a critical non-invasive test for preoperative diagnosis of ovarian
cancer. Deep learning is making advances in image-recognition tasks; therefore, we aimed to …

[HTML][HTML] MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma

…, S Druschitz, Y Liu, K Mittal, B Kong… - Modern …, 2014 - nature.com
Recent identification of somatic MED12 mutations in most uterine leiomyomas brings a new
venue for the study of the tumorigenesis of leiomyomas. We are particularly interested in the …

[HTML][HTML] Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro

…, S Yao, Z Li, X Su, X Ju, L Chao, X Deng, B Kong… - Scientific reports, 2017 - nature.com
Human umbilical cord mesenchymal stem cells (huMSCs) can treat primary ovarian
insufficiency (POI) related to ovarian granulosa cell (OGC) apoptosis caused by cisplatin …